Taylor Liu

Employment

• National Institutes of Health Post-bac IRTA
  2018 - 2021

Education

• University of California Los Angeles David Geffen School of Medicine

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells
  Julie Brault, Taylor Liu, Siyuan Liu +18 more
  Frontiers in Immunology 2023 DOI: 10.3389/fimmu.2022.1067417
  +Save
• Lentivector cryptic splicing mediates increase in CD34+ clones expressing truncated HMGA2 in human X-linked severe combined immunodeficiency
  Nature Communications 2022 DOI: 10.1038/s41467-022-31344-x
  +Save
• CRISPR-targeted MAGT1 insertion restores XMEN patient hematopoietic stem cells and lymphocytes
  Blood 2021 DOI: 10.1182/blood.2021011192
  +Save
• Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair
  Colin L. Sweeney, Mara Pavel-Dinu, Uimook Choi +13 more
  Gene Therapy 2021 DOI: 10.1038/s41434-021-00251-z
  +Save
• Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells
  Suk See De Ravin, Julie Brault, Ronald J. Meis +20 more
  Blood 2021 DOI: 10.1182/blood.2020008503
  +Save
• NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease
  Blood Advances 2020 DOI: 10.1182/bloodadvances.2020003224
  +Save
• MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease.
  Cytotherapy 2020 DOI: 10.1016/j.jcyt.2020.08.013
  +Save